CVS Health Stock Is An Early Gift At These Levels
MarketBeat.com | Nov 24, 2020 06:04AM ET
The nation’s second-largest drugstore operator CVS Health (NYSE: NYSE:CVS) stock got rug pulled on the rollout of Amazon Pharmacy (NASDAQ:AMZN). Shares of the vaccines near FDA approval, CVS could play a pivotal role as a mass distributor just as it has been for COVID-19 testing. Shares may provide deeper price discounts based on the weekly divergent top stochastic formation for prudent investors looking for opportunistic pullback entries.h3 Q3 FY 2020 Earnings Release /h3
On Nov. 6, 2020, CVS Health released its fiscal third-quarter 2020 results for the quarter ending September 2020. The Company reported an earnings-per-share (EPS) profit of $1.66 excluding non-recurring items versus consensus analyst estimates for a profit of $1.34, a $0.32 beat. Revenues grew 3.5% year-over-year (YoY) to $67.05 billion, beating analyst estimates for $66.54 billion. The Company also announced the appointment of Karen S. Lynch as the new CEO effective Feb. 1, 2021. Lynch is currently the Executive Vice President of CVS Health and Aetna (NYSE:AET). CVS raised its full-year 2020 EPS guidance to a range of $7.35 to $7.42, up from $7.14 to $7.27 versus $7.23 analyst consensus estimates.
h3 Conference Call Takeaways/h3CVS Health CEO, Larry Merlo, highlighted the Company’s multi-channel health services model delivering care to customers wherever and whenever. The Company serves over 100 million members across all its businesses. This creates powerful leverage as well as distribution potential for healthcare services. The next-gen Transform Diabetes Care program, “brings together our advanced data analytics with our clinical, brick-and-mortar and digital assets to provide a comprehensive solution that is personalized, predictive, and prioritized.” As of Jan. 1, the program had one million members with access to the program. The Company introduced a reduced and zero copay Minute Clinic benefit including E-Clinic virtual care for Medicare Advantage plans in 2021.
h3 Vertically Integrated Healthcare /h3CVS is the nation’s largest pharmacy benefits manager (PBM) responsible for nearly 50% of its top line, of which 33% is derived from its retail pharmacy business. The Amazon Pharmacy rollout may put some margin pressure on its retail pharmacy but should be offset by its organic growth. The acquisition of Aetna health insurance is transforming CVS into a complete vertically integrated powerhouse utilizing its brick and mortar stores to become healthcare distribution points as evidenced by COVID-19 testing (six million tests provided across 4,000 locations representing 70% of retail testing) and very likely for the distribution of COVID-19 vaccines.
h3 Pandemic Benefactor/h3
Get The News You Want
The Minute Clinics are already serving as viable routine and urgent care destinations for local communities. The synergies are the core engine for the HealthHubs initiative comprised of wellness and health clinics. With 205 HealthHubs currently, the Company plans to grow to 1,500 locations by year’s end 2021. The Health Advisor service data indicates a 12% reduction in unnecessary emergency room visits. About 70% of COVID-19 tested participants at CVS Pharmacy and 40% of the Return Ready B2B clients were not previous CVS health customers. This has become an indirect form of customer acquisition due to the pandemic further underscoring the Company as a pandemic benefactor for the long-term. Prudent investors looking for exposure in this value play should watch for opportunistic price pullback levels.
Using the rifle charts on the monthly and weekly time frames enables a broader view of the playing field. The monthly rifle chart is in a make or break with a tightening range but a divergent top stochastic as the 5-period moving avg (MA) crosses over the 15-period MA again. The monthly market structure low (MSL) triggered above the $60.40 Fibonacci (fib) level. The weekly rifle chart formed a bullish mini pup as shares launched through its upper Bollinger Bands at $71.74 before the Amazon Pharmacy news caused shares to plunge. Further pullbacks for a tightening towards its weekly 5-period MA can be expected. Prudent investors can watch for opportunistic pullback levels at the $63.74 weekly 5-period MA, $61.35 fib, $60.35 fib and the $58.54 fib. The upside trajectories range from the $70.65 daily MSH to $77.91 monthly upper BBs to the $83.58 fib.
Original Post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.